Vanguard Group’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $143M | Sell |
|
|||||
|
2020
Q2 | $70.2M | Buy |
|
|||||
|
2020
Q1 | $59.7M | Buy |
|
|||||
|
2019
Q4 | $135M | Buy |
|
|||||
|
2019
Q3 | $78.6M | Buy |
|
|||||
|
2019
Q2 | $77.2M | Buy |
|
|||||
|
2019
Q1 | $79.2M | Sell |
|
|||||
|
2018
Q4 | $87.9M | Buy |
|
|||||
|
2018
Q3 | $97.6M | Buy |
|
|||||
|
2018
Q2 | $92.6M | Buy |
|
|||||
|
2018
Q1 | $105M | Buy |
|
|||||
|
2017
Q4 | $97.8M | Sell |
|
|||||
|
2017
Q3 | $65M | Buy |
|
|||||
|
2017
Q2 | $50.9M | Buy |
|
|||||
|
2017
Q1 | $47.8M | Buy |
|
|||||
|
2016
Q4 | $34.5M | Buy |
|
|||||
|
2016
Q3 | $22.8M | Buy |
|
|||||
|
2016
Q2 | $14.5M | Buy |
|
|||||
|
2016
Q1 | $16.7M | Buy |
|
|||||
|
2015
Q4 | $12.9M | Buy |
|
|||||
|
2015
Q3 | $14.3M | Buy |
|